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Abstract
The food enzyme considered in this opinion is a b-amylase (EC 3.2.1.2) from soybean whey, submitted
by Nagase (Europa) GmbH. This b-amylase is intended to be used in the starch processing for maltose
syrup production and the manufacture of a Japanese rice cake type. Based on the maximum use levels
recommended for the respective food processes, dietary exposure to the food enzyme–total organic
solids (TOS) was estimated on the basis of Japanese consumption data. Conservative average infant
formula consumption, as reported in the EFSA Draft Guidance on risk assessment of substances
present in food intended for infants below 16 weeks of age, was used to estimate the exposure to a
fraction of soybean comparable to the food enzyme–TOS, resulting from the consumption of soybean-
derived foods. The exposure estimate to the food enzyme–TOS was found to be lower than the
comparable fraction from the source material. Potential allergenicity of the b-amylase was evaluated by
searching for similarity of the amino acid sequence to those of known allergens, and no match was
found. The b-amylase is produced from soybean, which is a known allergenic food. Japanese rice
cake, consequently, may contain traces of soybean allergens, which may give rise to safety concerns in
soybean-allergic consumers. Based on the origin of the food enzyme from edible parts of soybean, the
manufacturing process, the compositional and biochemical data provided and the dietary intake
estimates, the Panel concluded that this food enzyme does not give rise to safety concerns under the
intended conditions of use, except that Japanese rice cake produced with this food enzyme may
contain traces of soybean allergens.
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1. Introduction
Article 3 of the Regulation (EC) No 1332/20081 provides deﬁnition for ‘food enzyme’ and ‘food
enzyme preparation’:
• ‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products
thereof including a product obtained by a fermentation process using microorganisms:
(i) containing one or more enzymes capable of catalysing a speciﬁc biochemical reaction; and
(ii) added to food for a technological purpose at any stage of the manufacturing, processing,
preparation, treatment, packaging, transport or storage of foods.
• ‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in
which substances, such as food additives and/or other food ingredients, are incorporated to
facilitate their storage, sale, standardisation, dilution or dissolution.
Before January 2009, food enzymes other than those used as food additives were not regulated or
were regulated as processing aids under the legislation of the Member States. On 20 January 2009,
Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes
that are added to food to perform a technological function in the manufacture, processing,
preparation, treatment, packaging, transport or storage of such food, including enzymes used as
processing aids. Regulation (EC) No 1331/20082 established the European Union (EU) procedures for
the safety assessment and the authorisation procedure of food additives, food enzymes and food
ﬂavourings. The use of a food enzyme shall be authorised only if it is demonstrated that:
• it does not pose a safety concern to the health of the consumer at the level of use proposed,
• there is a reasonable technological need, and
• its use does not mislead the consumer.
All food enzymes currently on the EU market and intended to remain on that market, as well as all
new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority
(EFSA) and approval via an EU Community list.
The ‘Guidance on submission of a dossier on a food enzyme for evaluation’ (EFSA, 2009a) lays
down the administrative, technical and toxicological data required.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background as provided by the European Commission
Only food enzymes included in the Union list may be placed on the market as such and used in
foods, in accordance with the speciﬁcations and conditions of use provided for in Article 7 (2) of
Regulation (EC) No 1332/2008 on food enzymes.
An application has been introduced by Nagase (Europa) GmbH for the authorisation of the food
enzyme b-amylase obtained from whey of soybean (Glycine max).
Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/20113
implementing Regulation (EC) No 1331/2008, the Commission has veriﬁed that the application falls
within the scope of the food enzyme Regulation and contains all the elements required under
Chapter II of that Regulation.
1 Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and
Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive
2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7–15.
2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food ﬂavourings. OJ L 354, 31.12.2008, p. 1–6.
3 Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European
Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food
ﬂavourings. OJ L 64, 11.3.2011, p. 15–24.
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1.1.2. Terms of Reference
The European Commission requests EFSA to perform the safety assessment on the food enzyme
b-amylase obtained from soybean in accordance with Article 17.3 of Regulation (EC) No 1332/2008 on
food enzymes.
1.1.2.1. Interpretation of the Terms of Reference
In the mandate from the European Commission, EFSA was requested to carry out the safety
assessment of b-amylase from soybean. Evaluation of the production process made clear that this
enzyme is extracted from the whey of soybean. In order to maintain consistency between the actual
source material and the scope of the scientiﬁc assessment, EFSA considers soybean whey as the
source of the b-amylase described in this application.
1.2. Information on existing authorisations
According to the applicant, the authorities of Japan have evaluated and authorised the use of
b-amylase obtained from soybean whey.
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier in support of the application for authorisation of the food
enzyme b-amylase obtained from whey of soybean. The food enzyme is intended to be used in the
production of maltose syrup and for rice cake manufacture.
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA Guidance on
transparency in the scientiﬁc aspects of risk assessment (EFSA, 2009b) and following the relevant
existing Guidances from the EFSA Scientiﬁc Committee.
The current ‘Guidance on the submission of a dossier for safety evaluation of a food enzyme’
(EFSA, 2009a) has been followed for the evaluation of this application with the exception of the
exposure assessment, which was carried out in accordance to the principle described in the CEF
Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016).
3. Assessment
3.1. Technical data
3.1.1. Identity of the food enzyme
IUBMB nomenclature: b-amylase
Systematic name: 4-a-D-glucan maltohydrolase
Synonyms: Saccharogen amylase, glycogenase, 1,4-a-D-glucan maltohydrolase
IUBMB No: EC 3.2.1.2
CAS No: 9000-91-3
EINECS No: 232-566-1
The food enzyme is obtained via aqueous extraction from soybean whey.
3.1.2. Chemical parameters
b-Amylase obtained from whey of soybean consists of a single polypeptide chain of 496 amino
acids. The 56 kDa molecular mass was calculated from the amino acid sequence deduced from the
cDNA sequence (http://www.uniprot.org/uniprot/P10538). The applicant provided a sodium dodecyl
sulfate-poly acrylamide gel electrophoresis (SDS-PAGE) analysis of six food enzyme batches in Table 1.
Results indicate that the batch-to-batch variability is minimal. A band corresponding to the b-amylase
and a more intensely stained band with a same molecular mass as the soybean lectin monomer were
found in each of the six batches of product analysed.
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Data on chemical parameters of the food enzyme were provided for six commercial food enzyme
batches. Three commercial food enzyme batches (1, 2 and 3) represent the original manufacturing
process at the time of submission of the application; three other food enzyme batches (4, 5 and 6)
represent a revised manufacturing process as of October 2016 (Table 1). The revised manufacturing
process differs from the original process by omitting the use of and
as process chemicals. Despite the change in the production process, the
Panel considered that the batches are equivalent for the safety evaluation.
The total organic solids (TOS) content is a calculated value derived as 100% food enzyme minus %
water content minus % ash. The average TOS content of all six commercial batches was 79.9% (w/w).
The average enzyme activity/TOS ratio of the commercial food enzyme batches was 44.2 amylolytic
unit of Nagase (AUN)/mg TOS.
All six commercial batches of food enzyme were tested for other enzyme activities (protease,
a-amylase and lipase), which were below the detection limits of the employed methods.4
The applicant provided data for all six commercial batches demonstrating that the contents of lead,
arsenic and mercury were below the limit of detection (LoD),5 consequently well below the limit set for
lead (< 5 mg/kg) for enzymes used in food processing (FAO/WHO, 2006). The Panel considered that
the measured level of cadmium and the LoD for arsenic and mercury, in the presented batches,
are not of concern as they are well below the speciﬁcation levels set for food additives (As: 3 mg/kg;
Cd and Hg: 1 mg/kg).6
The food enzyme complies with the microbiological criteria as laid down in the general
speciﬁcations and considerations for enzymes used in food processing (FAO/WHO, 2006), which
stipulate that Escherichia coli and Salmonella species are absent in 25 g of sample and total coliforms
are not more than 30 colony-forming units (CFU)/g.
The applicant provided a statement that the original three batches (1, 2 and 3) of the food enzyme
complies with the Maximum Residue Limits of pesticides set in the Japanese Positive List System for
Agricultural Chemical Residues in Foods.7 The applicant provided data on the absence of mycotoxins in
food enzyme batches. In addition, the applicant has put in place a quality assurance system to
minimise potential contamination of the soybean whey with mycotoxins.
Antifoam agents are being used in the course of the manufacturing process. The applicant has
provided information on their identity, their use levels and methods for their analysis. Taking into
account the nature, the properties and the very low amounts of the antifoam agents, the
manufacturing process and the quality assurance system implemented by the applicant, the
Panel considers their use as of no safety concern.
The Panel considered the compositional data provided for the food enzyme as sufﬁcient.
Table 1: Compositional data provided for six commercial production batches
Parameter Unit
Batches
1 2 3 4 5 6
b-Amylase
activity
AUN/g batch(a) 32,680 34,580 35,980 35,740 37,850 34,910
Protein mg/g 442 452 476 504 526 498
Ash % 10.4 10.1 10.0 15.1 12.2 12.1
Water % 8.3 8.6 8.7 8.5 8.3 8.4
Total organic
solids (TOS)(b)
% 81.3 81.3 81.3 76.4 79.5 79.5
b-Amylase
activity/mg
TOS
AUN/mg
TOS
40.20 42.53 44.26 46.78 47.61 43.91
(a): AUN/g batch: amylolytic unit of Nagase (see Section 3.1.3).
(b): TOS calculated as 100% - % water - % ash.
4 Limit of detection: 2 PUN (proteolytic unit of Nagase)/g for protease; 1 DUN (dextrinometric unit of Nagase)/g for a-amylase;
10 LUN (lipolytic unit of Nagase)/g for lipase.
5 Limits of detection for Pb: 0.05 mg/kg; As: 1 mg/kg; Cd: 0.01 mg/kg; Hg: 0.01 mg/kg.
6 Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in
foodstuffs. OJ L 364/5, 20.12.2006.
7 Available online at: http://www.ffcr.or.jp/zaidan/ffcrhome.nsf/pages/mrls-p
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3.1.3. Properties of the food enzyme
b-Amylase catalyses the hydrolysis of 1,4-a-glycosidic linkages in polysaccharides and releases
successively maltose units from the non-reducing ends of the chains.
b-Amylase activity is quantiﬁed based on the measurement of released reducing sugars from
hydrolysis of soluble starch and is expressed in AUN/g. The analytical principle is based on the
reduction of copper (II) to copper (I). The excess of copper (II) oxidises iodide to iodine, which is
titrated by thiosulfate. One AUN is deﬁned as the amount of enzyme that will produce reducing sugars
equivalent to 1 mg of glucose in 10 min and at 40°C.
The b-amylase has been characterised regarding its activity depending on temperature and pH. At
pH 5.5, b-amylase is active at temperatures up to the 70°C (approximately 50% relative activity at
70°C, with an optimum of about 60°C). The pH proﬁle has been measured within a pH range of
3.0–7.5 at 30°C (50% relative activity at pH 3.0 and about 70% relative activity at pH 7.5, with an
optimum about pH 5.5. The thermostability of the b-amylase was tested over the range of 10–70°C at
pH 5.5 after incubation at different temperatures for 30 min. The stability, measured under standard
assay conditions, decreases rapidly above 60°C within 30 min incubation and no activity is measured
after 30 min incubation at 70°C.
3.1.4. Information on the plant source material
The food enzyme is obtained from the whey of non-genetically modiﬁed soybean suitable for
human consumption. The applicant provided a statement on the implementation of a quality system
ensuring compliance of the raw material with Positive List System for Agricultural Chemical Residues in
Food in Japan.
The soy whey is the ﬁltrate obtained from acid-precipitated curd, a by-product from tofu
manufacture. Soy protein ingredients play functional roles in baked foods, processed meats and other
products. Applications in edible gums and detergents are also mentioned (Smith et al., 1962).
Soybeans have a long history of use in food (Erdman and Fordyce, 1989). However, soybean is also
known to be a common food allergen (reviewed by Katz et al., 2014) and listed in Annex II of
Regulation (EU) No 1169/20118 among the substances or products causing allergies or intolerances
that should be labelled.
3.1.5. Manufacturing process
A comprehensive data set related to the manufacturing process including a list of raw materials
used and a ﬂow diagram was provided. The food enzyme is manufactured in accordance with
procedures based on Hazard Analysis and Critical Control Points (HACCP) principles, and following
Good Manufacturing Practice (GMP).
The extraction process consists of a pretreatment and a preservation step. The absence of
signiﬁcant microbial contamination is analysed after the ﬁrst ﬁltration steps, before sedimentation.
In the solid/liquid separation, insoluble soybean solids are removed from the solution containing the
enzyme. The food enzyme is separated from insoluble soybean materials by several ﬁltration and
puriﬁcation steps.
After separation, the liquid containing the enzyme is concentrated to reach the desired enzyme
activity and/or to increase the enzyme activity/TOS ratio. Concentration may be achieved by
ultraﬁltration, diaﬁltration and/or evaporation. At the end of this process, the yield of TOS from
soybean whey is , and from soybeans the yield is .
The Panel considered the information provided on the raw materials and the manufacturing process
as sufﬁcient.
3.1.6. Reaction and fate in food
b-Amylase catalyses the cleavage of 1,4-a-glycosidic linkages in the starch polysaccharides amylose
and amylopectin, resulting in the successive removal of maltose units from the non-reducing ends of
the starch chains.
8 Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and
of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/
EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC
and Commission Regulation (EC) No 608/2004. OJ L 304, 22.11.2011, p. 18–63.
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b-Amylase is speciﬁc in its action and not known to catalyse reactions other than the hydrolysis of
the starch polysaccharides amylopectin and amylose. The reaction products, i.e. maltose and the
remaining oligosaccharides, are naturally present in starch-containing foods.
It is reported in the dossier that b-amylase is inactivated during the processing in the rice cake
production and removed from glucose syrups through the puriﬁcation steps involving an ion-exchange
chromatography during processing under the intended use conditions.
3.1.7. Case of need and intended conditions of use
The food enzyme is intended to be used in maltose syrup production9 and in rice cake manufacture
as was provided by the applicant (Table 2).
In maltose syrup production, b-amylase is added to the liqueﬁed starch before the sacchariﬁcation
step, in order to convert liqueﬁed starch into a maltose rich solution. This solution is puriﬁed and
concentrated to a maltose syrup, to be used as a sweetener in a number of foodstuffs.
In the manufacture of Japanese rice cake, b-amylase is added to the processed rice ﬂour,
containing starch and sweeteners, before toasting/boiling of the cake. b-Amylase is used in order
prevent the starch retrogradation after cooling.
According to the applicant, the food enzyme is used at the minimum dosage necessary to achieve
the desired reaction according to GMP.
3.2. Dietary exposure
Following the EFSA Guidance Document on food enzymes (EFSA, 2009a) a comparison was made
between:
• dietary exposure to the food enzyme–TOS, resulting from the intended use as proposed by the
applicant (herein referred to as ‘FE–TOS’); and
• dietary exposure to a fraction of soybean comparable to the food enzyme–TOS, resulting from
the consumption of soybean-derived foods (herein referred to as source material equivalent,
‘SMT-Equivalent’).
The Japanese consumption data reported in the FAO/WHO Chronic Individual Food Consumption
Summary Statistics (CIFOCOss10) database was used to estimate the exposure to the FE–TOS. The
conservative average infant formula consumption, as reported in the EFSA Draft Guidance on risk
assessment of substances present in food intended for infants below 16 weeks of age, was used to
estimate the exposure to the SMT-Equivalence.
3.2.1. Exposure to food enzyme–TOS according to the intended use proposed by
the applicant
Exposure to the FE–TOS was estimated based on the intended use and the maximum
recommended use level of the food enzyme (Table 2).
Foods/ingredients derived through starch processing, i.e. maltose syrup, were excluded from the
analysis. Experimental data on the signiﬁcant removal (> 99%) of protein in the course of this process
have been provided (documentation provided to EFSA, number 4). The Panel considered this evidence as
sufﬁcient to conclude that the presence of residual amounts of TOS after starch processing is negligible.
Table 2: Intended uses and recommended use levels of the food enzyme as provided by the
applicant
Food manufacturing process Raw material
Recommended use level
(mg TOS/kg RM)
Starch processing for maltose syrup production Starch 350–1,170
Japanese rice cake manufacture Rice ﬂour 4–24
TOS: total organic solids; RM: raw material.
9 The description provided by the applicant has been harmonised by EFSA according to the ‘EC working document describing
the food processes in which food enzymes are intended to be used’ - not yet published at the adoption of this opinion.
10 https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G7/PROD/EXT/CIFOCOSS_Country&userid=G7_ro&pass
word=inetsoft123
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The second intended use concerns the production of the Japanese rice cake (known as ‘mochi’),
which requires the use of glutinous rice (Oryza sativa var. glutinosa) ﬂour,11 a variety that is not
commonly used in the European diet. The Japanese rice cake ‘mochi’ is a niche product; only few
products can be found on the European market.12 No consumption records could be found in the
Comprehensive Database. However, it is known that the Japanese rice cake is sold in speciality food
shops or restaurants in Europe. Consequently, the Panel decided to use Japanese consumption data as
an alternative indicator for exposure, since this is expected to be an over-estimation for any
consumption that may arise in Europe.
Food consumption data for Japan were retrieved from the FAO/WHO CIFOCOss database. This data
set was considered an appropriate alternative, since the intended use is for the production of a
Japanese rice cake, consumed in Japan.
Summary statistics for chronic food consumption in Japan are available in the Japanese National
Health and Nutrition Survey.13 Different types of rice cakes (ﬁlled) are coded under the category
‘traditional confectioneries’.14 The closest matching food group, namely ‘sugar products and
confectionaries’ was retrieved from the CIFOCOss database. An ingredient factor of 0.3 was applied to
account for the rice ﬂour part in a typical ﬁlled Japanese rice cake.15 Accordingly, one serving contains
30 g of mochi rice ﬂour, equivalent to 2.5 and 0.4 g rice ﬂour/kg body weight (bw) per serving in a
12-kg child and 70-kg adult, respectively.
Table 3 provides an overview of the derived rice ﬂour intake from consumption of ‘sugar products
and confectionaries’ in the Japanese population and the subsequent exposure to the FE–TOS based on
the maximum intended use level of 24 mg/kg rice ﬂour indicated by the applicant.
3.2.2. Dietary exposure to the SMT-Equivalent
From the Japanese data, the highest exposure to the FE–TOS was found in children. The Japanese
consumption data did not distinguish between the age groups of the child population. Since infants
and young children are considered to be the most exposed population group (EFSA, 2011), the
Panel considered the consumption of soy-based infant formula by infants as suitable comparator for
intake of the SMT-Equivalent.
According to the draft scientiﬁc committee ‘guidance on the risk assessment of substances present
in food intended for infants’,16 the recommended conservative mean intake of infant formula by an
infant is approximately 200 mL/kg bw per day. To convert the intake into raw powder a conversion
factor of eight17 was applied, resulting in an equivalent powder intake of 25 g/kg bw. According to
Commission Directive 2006/141/EC18, infant formula is to contain a protein content of 1.8 g/100 g
infant formula powder. Assuming that all protein is derived from soy hydrolysate, intake of 25 g infant
formula powder/kg bw per day would result in intake of 0.45 g soy-derived protein/kg bw per day.
Table 3: Summary of estimated dietary exposure to the FE–TOS in the Japanese population
Japanese consumption data
(g/kg bw per day)
Estimated exposure to FE–TOS
(mg/kg bw per day)
Children* General population* Children General population
Min–max mean
(number of surveys)
0.03–0.76 (4) 0.0–0.27 (4) 0.0–0.01 (4) 0.0–0.02 (4)
Min–max 95th percentile
(number of surveys)
0.2–1.93 (4) 0.03–0.91 (4) 0.02–0.15 (4) 0.0–0.07 (4)
bw: body weight.
*: Age not speciﬁed.
11 http://www.newworldencyclopedia.org/entry/Mochi
12 Retrieved from the Mintel GNPD Database on 1 March 2017.
13 http://www0.nih.go.jp/eiken/english/research/project_nhns.html
14 Outline of the National Health and Nutrition Survey Japan, 2011. Available at http://www0.nih.go.jp/eiken/english/research/
pdf/nhns2011.pdf
15 Derived from http://allrecipes.com/recipe/193307/easy-mochi/
16 Version used for a publication consultation - at the time of adoption of this opinion - available at https://www.efsa.europa.eu/
en/consultations/call/170113-0
17 As typically used by EFSA in data conversion.
18 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive
1999/21/EC. OJ L 401, 30.12.2006, p. 1–33.
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Soybeans contain 36% of protein,19 therefore, the equivalent amount of soybean required to provide
0.45 g of soy protein is 1.25 g of soybean. According to the applicant, the yield of FE–TOS from the
raw soy bean material is %, which when applied to the 1.25 g of soy bean required to produce
the required protein content in the infant formula equates to mg/kg bw SMT-Equivalent (i.e.
fraction of soybean) comparable to the FE–TOS.
For infant formulae, an estimation was made as follows:
• intake of 200 mL formula/kg bw per day as a conservative average level consumption value
• infant formula has 1.8 g of protein in 100 g powder
• assuming that 100% of protein source in infant formula is soy protein
• The protein content of soybeans is about 36% (USDA and McCance & Widdowson Table)
[(200 mL/8) 9 1.8% protein content]/36% protein in bean = 1.25 g soybean/kg bw
1.25 9 % TOS/soybean yield = g/kg bw = mg SMT-Equivalent/kg bw
The suitability of using infant formula consumption in infants to cover the entire population was
validated by assessing soy drink consumption by adults. Seven soybean-derived foods20 were reported
in the EFSA Comprehensive Food Consumption Database.21 In the case of soy drink, the highest
number of consumers (88) was identiﬁed in Germany with the mean and 95th percentile consumption
of 2.5 and 7.7 g/kg bw, respectively. With the exception of soybean oil, consumption data for other
soybean-derived foods was scarcer and/or the percentage of soybean as an ingredient in these foods
was small. Therefore, the Panel considered the intake of 2.5 and 7.7 g/kg bw soya drink as an
indicator for the consumption of soybean-derived food in adults in order to assess consumption of the
SMT-Equivalent.
Soya drink contains about 5.8%17 soybean. Consequently, the consumption of 2.5 and 7.7 g of
soya drink is equal to 0.15 and 0.45 g of soybean. Applying the yield factor of %, to the
consumption of 0.15 and 0.45 g of soybean equates to the mean and 95th percentile intake of and
mg/kg bw SMT-Equivalent comparable to the FE-TOS, respectively.
3.2.3. Comparison of the exposure estimates
Exposure to the food enzyme from consumption of the intended use (i.e. Japanese rice cake
‘mochi’), calculated on the basis of FE–TOS (Table 3), was two orders of magnitude lower (approx.
3 9 102) than the exposure to the SMT-Equivalent comparable to the FE–TOS, resulting from the
consumption of soybean-derived infant formula. A similar difference in magnitude (approx. 2 9 102)
was seen in adults, when only soya drink was considered. The Panel considered the assessment for
infants sufﬁcient to conclude on the safety for the whole population.
3.2.4. Uncertainty analysis
Uncertainties in the exposure assessment were identiﬁed and discussed with regard to their impact
on the ﬁnal exposure calculation.
In accordance with the guidance provided in the EFSA Opinion related to uncertainties in dietary
exposure assessment (EFSA, 2007), the following sources of uncertainties have been considered and
are summarised in Table 4.
19 Available at https://www.gov.uk/government/publications/composition-of-foods-integrated-dataset-cofid
20 Soya bread, soybean (Glycine max), soya drink, soy sauce, soybean oil, textured soy protein, soya yoghurt.
21 Available at http://www.efsa.europa.eu/en/food-consumption/comprehensiveglucaatabase
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Different sources of food consumption data were used in deriving exposure estimates to FE–TOS
and the SMT-equivalent, and should not be compared directly. However, the observed levels provide an
indication for the difference in level of exposure from either the FE–TOS or the SMT-Equivalent.
The approach applied to the exposure estimate to food enzyme–TOS is likely to have led to an
overestimation of the exposure applicable to the European population. For the estimation of intake of
the SMT-Equivalent, uncertainties taken into account do not indicate either over- or underestimation of
intake.
Overall, the Panel noted that the impact of the various uncertainties identiﬁed, on the estimated
exposure levels derived for the purposes of establishing evidence of safe history of use are small.
3.3. Toxicological data
According to the Commission Implementing Regulation (EU) No 562/201222, an application for the
safety evaluation of a food enzyme does not need to include toxicological data if the food enzyme is
obtained from edible parts of a plant intended or reasonably expected to be ingested by humans.
According to the EFSA Guidance on the submission of a dossier on food enzymes for safety
evaluation, the justiﬁcation for not supplying toxicological data may include a documented history on
the safety of the source of the food enzyme, the composition and the properties of the food enzyme,
as well as its use in foods, demonstrating no adverse effects on human health when consumed in a
comparable way (EFSA, 2009a).
The Panel considers these requirements as being fulﬁlled because:
1) soybean and soy products are routinely eaten in many parts of the world (Erdman and
Fordyce, 1989).
Table 4: Qualitative evaluation of the inﬂuence of uncertainties on the dietary exposure estimate
Sources of uncertainties
Direction of impact
Exposure to
FE–TOS
Exposure to comparable
SMT-Equivalent
Model input data
Use of Japanese consumption data as indicator for European
population exposure to a traditional Japanese food
+ NA
Japanese consumption data: representativeness/underreporting/
misreporting/no portion size standard
+/ NA
Use of the food category ‘sugar products and confectionaries’ + NA
Different source of food consumption data for the estimation of the
FE–TOS and the SMT-equivalent
+/ +/
Use of intake recommendation for infant formula NA +
Model assumptions and factors
Food categories included in the exposure assessment were assumed
to always contain the FE–TOS
+ NA
Exposure to FE–TOS was calculated based on the maximum
recommended use level
+ NA
Use of recipe fractions in disaggregating the rice cake and soy drink +/ +/
Extrapolation from infant exposure to entire population NA +
Assuming that all protein in infant formula is derived from soy
protein
NA +
Use of legal recommendation to derive the protein content of soy-
based infant milk
NA +/
Percent protein in soybean was assumed to be 36% NA +/
+: uncertainty with potential to cause overestimation of exposure; : uncertainty with potential to cause underestimation of
exposure; NA: not applicable.
22 Commission Implementing Regulation (EU) No 562/2012 of 27 June 2012 amending Commission Regulation (EU)
No 234/2011 with regard to speciﬁc data required for risk assessment of food enzymes. OJ L 168, 28.6.2012, p. 21–23.
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2) soy whey used for the production of the food enzyme complies with the legal requirements
regarding limits of potential contaminants and residues in the country of manufacture. The
manufacturing process of the food enzyme is not considered to introduce substances that
could raise safety concerns.
3) the compositional data provided on the food enzyme are considered sufﬁcient.
Exposure to the food enzyme, calculated on the basis of food enzyme–TOS, is lower than the
exposure to the SMT-Equivalent.
3.4. Allergenicity
Potential allergenicity of b-amylase from whey of soybean was assessed by comparing the amino
acid sequence deduced from the cDNA sequence (http://www.uniprot.org/uniprot/P10538) with those
of known allergens according to the EFSA Scientiﬁc opinion on the assessment of allergenicity of GM
plants and microorganisms and derived food and feed of the Scientiﬁc Panel on Genetically Modiﬁed
Organisms (EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino
acids as the criterion; no matches were found.
Soybean b-amylase is not described as a potential allergen and no food allergic reactions to
soybean b-amylase have been reported, so there is no evidence for potential allergenicity of the
b-amylase from soybean whey. However, the food enzyme is derived from soybean, i.e. one of the
substances or products causing allergies or intolerances8 and therefore the enzyme might contain
traces of soybean allergens (reviewed by Batista et al., 2007).
The sugar syrups produced with the food enzyme are not considered to be of concern regarding
allergenicity given the absence of exposure as the food enzyme is removed during processing. The
only food to be treated with soybean b-amylase, which may contain traces of soybean, is Japanese
rice cake, which may give rise to safety concerns for soybean-allergic consumers.
Overall, the Panel considered that for sugar syrups produced with this food enzyme, there is no
concern with respect to allergenicity, but that Japanese rice cake produced with this food enzyme may
contain traces of soybean allergens.
Conclusions
Based on the manufacturing process and the compositional and biochemical data provided, and taking
into account the dietary intake assessment, the Panel considered the food enzyme b-amylase obtained
from soybean not to give rise to safety concerns under the intended conditions of use, except that
Japanese rice cake produced with this food enzyme may contain traces of soybean allergens.
Documentation provided to EFSA
1) Dossier ‘Request for the authorization of a b-amylase preparation from Glycine max for use
as a food processing aid’. March 2015. Submitted by Nagase (Europa) GmbH.
2) Additional information received from Nagase (Europa) GmbH in October 2016 regarding
protein analysis, process chemicals, typing errors, raw material and yield.
3) Additional information received from Nagase (Europa) GmbH in January 2017 regarding
certiﬁcates of analysis, analysis methods for heavy metals, protein content, quality assurance
systems, antifoams, protein analysis and conﬁdentiality.
4) Additional information on ‘Food enzyme removal during the production of cereal based
distilled alcoholic beverages’ and ‘Food enzyme carry-over in glucose syrups’. 22 February
2017. Provided by the Association of Manufacturers and Formulators of Enzyme Products.
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Abbreviations
AUN amylolytic unit of Nagase
Bw body weight
CAS Chemical Abstracts Service
CEF EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CFU colony-forming units
CIFOCOss Chronic Individual Food Consumption Summary Statistics
DUN dextrinometric unit of Nagase
EC Enzyme Commission
EINECS European Inventory of Existing Commercial Chemical Substances
FAO Food and Agricultural Organization
GMP Good Manufacturing Practice
HACCP Hazard Analysis and Critical Control Points
IUBMB International Union of Biochemistry and Molecular Biology
JECFA Joint FAO/WHO Expert Committee on Food Additives
LoD limit of detection
LUN lipolytic unit of Nagase
PUN proteolytic unit of Nagase
SDS-PAGE sodium dodecyl sulfate-poly acrylamide gel electrophoresis
SMT source material
TOS total organic solids
WHO World Health Organization
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